Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.
ANH
1 other identifier
interventional
2,000
11 countries
32
Brief Summary
Transfusions are one of the most overused treatments in modern medicine, and saving blood is one important issue all around the world. Cardiac surgery makes up a large percentage of the overall blood components consumption in surgery. Acute normovolemic hemo-dilution (ANH) is a well-known strategy which has been used for years without the support of high quality evidence based medicine to improve post-cardiopulmonary bypass coagulation and reduce red blood cells (RBC) transfusion. We designed a multicenter randomized controlled trial to investigate the effect of ANH in reducing the number of cardiac surgery patients receiving RBC transfusions during hospital stay. We will randomize 2000 patients to have sufficient power to demonstrate a 20% relative and 7% absolute risk reduction in the number of patients' RBC transfusion. If the results of the study will confirm our hypothesis, this will have a great impact on blood management in cardiac operating room.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
32 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2019
CompletedFirst Posted
Study publicly available on registry
April 12, 2019
CompletedStudy Start
First participant enrolled
April 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 7, 2025
August 1, 2025
5.8 years
April 9, 2019
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
RBCs transfusion
The number of patients receiving RBCs transfusion after elective cardiac surgery.
hospital discharge, an average of 10 days
Secondary Outcomes (4)
Mortality
30 days
Bleeding complications
hospital discharge, an average of 10 days
Ischemic complications
hospital discharge,an average of 10 days
AKI
hospital discharge, an average of 10 days
Study Arms (2)
ANH
EXPERIMENTALBest available treatments plus ANH, performed withdrawing a volume of blood before the CPB. The volume will be personalized for every patient, but it'll be at least 650ml.
Standard care
OTHERNo ANH
Interventions
In the ANH arm, after induction of general anesthesia, a total blood volume of at least 650 ml of blood will be drawn from a central line. The amount of volume drawn can be replaced with Ringer lactate or a similar crystalloid fluid up to a 3:1 ratio.
Eligibility Criteria
You may qualify if:
- Signed informed consent
- Any cardiac surgical intervention on CPB
- Elective surgery
You may not qualify if:
- Medical decision (e.g.: planned pre-CPB ANH considered undeniable for ethical reasons or not applicable for safety issues)
- Unstable Coronary Artery Disease: Recent (\< 6 weeks) myocardial infarction, unstable angina, severe (\> 70%) left main coronary artery stenosis
- Critical preoperative state (ventricular tachycardia or ventricular fibrillation or aborted sudden death, preoperative cardiac massage, preoperative ventilation before anesthetic room, hemodynamic instability, preoperative inotropes or IABP, preoperative severe acute renal failure (anuria or oliguria \<10ml/hr.)
- Emergency surgery
- Pregnancy
- Unfeasibility to withdraw ≥ 650 ml without inducing hemodynamic instability
- Unfeasibility to withdraw ≥ 650 ml without inducing pre-CPB anemia (Htc \<30%)
- Unfeasibility to withdraw ≥ 650 ml without inducing low Htc during CPB (Htc \<24%)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (32)
OUHSC - University of Oklahoma
Oklahoma City, Oklahoma, 73104, United States
University of Virginia
Charlottesville, Virginia, 22903, United States
Mohammed Bin Khalifa Specialist Cardiac Center
Awali, Bahrain, Bahrain
Dante Pazzanese Institute od Cardiology
São Paulo, 04012-909, Brazil
Instituto do Coração - Hospital das Clínicas, Faculdade de Medicina - Universidade de São Paulo
São Paulo, 05403-000, Brazil
Xijing Hospital
Xi'an, 710032, China
Maria Cecilia Hospital
Cotignola, Ravenna, Italy
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco"
Catania, 95123, Italy
Città di Lecce Hospital - GVM Care & Research
Lecce, 73100, Italy
IRCCS Policlinico San Donato
Milan, 20097, Italy
IRCCS Cardiologico Monzino
Milan, 20138, Italy
Ospedale San Raffaele di Milano, Italy
Milan, 20132, Italy
Azienda Ospedaliera Padova
Padua, 35129, Italy
AOU Pisana
Pisa, 56126, Italy
Ospedale San Carlo
Potenza, 85100, Italy
Policlinico Tor Vergata
Rome, 00133, Italy
Azienda Ospedaliero-Universitaria Sant'Andrea
Rome, 00189, Italy
Istituto Clinico Humanitas
Rozzano, 20089, Italy
San Giovanni di Dio e Ruggi d'Aragona
Salerno, 84131, Italy
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
Torino, 10126, Italy
Azienda Ospedaliera Ordine Mauriziano di Torino
Torino, 10128, Italy
Azienda Sanitaria Universitaria Integrata di Udine
Udine, 33100, Italy
Astrakhan Centre For Cardiac Surgery
Astrakhan, 414011, Russia
Moscow Clinical Scientific Center named after Loginov
Moscow, 111123, Russia
Vishnevsky National Medical Research Center of Surgery
Moscow, 117997, Russia
E. Meshalkin National Medical Research Center
Novosibirsk, Russia
Saint-Petersburg State University Hospital
Saint Petersburg, 190103, Russia
King Abdullah Medical City
Mecca, 24246, Saudi Arabia
Institute of Cardiovascular Diseases "Dedinje"
Belgrade, 11040, Serbia
National University Hospital
Singapore, 119074, Singapore
Chiang Mai University Hospital
Chiang Mai, 50200, Thailand
Kosuyolu High Specialization Education and Research Hospital
Istanbul, 34903, Turkey (Türkiye)
Related Publications (3)
Monaco F, Guarracino F, Vendramin I, Lei C, Zhang H, Lomivorotov V, Osinsky R, Efremov S, Gurcu ME, Mazzeffi M, Pasyuga V, Kotani Y, Biondi-Zoccai G, D'Ascenzo F, Romagnoli E, Nigro Neto C, Do Nascimento VTNDS, Ti LK, Lorsomradee S, Farag A, Bukamal N, Brizzi G, Lobreglio R, Belletti A, Arangino C, Paternoster G, Bonizzoni MA, Tucciariello MT, Kroeller D, Di Prima AL, Mantovani LF, Ajello V, Gerli C, Porta S, Ferrod F, Giardina G, Santonocito C, Ranucci M, Lembo R, Pisano A, Morselli F, Nakhnoukh C, Oriani A, Pieri M, Scandroglio AM, Kirali K, Likhvantsev V, Longhini F, Yavorovskiy A, Bellomo R, Landoni G, Zangrillo A. Acute normovolemic hemodilution in cardiac surgery: Rationale and design of a multicenter randomized trial. Contemp Clin Trials. 2024 Aug;143:107605. doi: 10.1016/j.cct.2024.107605. Epub 2024 Jun 10.
PMID: 38866095BACKGROUNDBarile L, Fominskiy E, Di Tomasso N, Alpizar Castro LE, Landoni G, De Luca M, Bignami E, Sala A, Zangrillo A, Monaco F. Acute Normovolemic Hemodilution Reduces Allogeneic Red Blood Cell Transfusion in Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Trials. Anesth Analg. 2017 Mar;124(3):743-752. doi: 10.1213/ANE.0000000000001609.
PMID: 27669554BACKGROUNDMonaco F, Lei C, Bonizzoni MA, Efremov S, Morselli F, Guarracino F, Giardina G, Arangino C, Pontillo D, Vitiello M, Belletti A, Ajello V, Licheri M, Nigro Neto C, Barucco G, Bukamal NA, Faustini C, Mantovani LF, Oriani A, Santonocito C, Mucchetti M, Federici F, Gerli C, Porta S, Scandroglio AM, Zhang H, Pieri M, Osinsky R, Lazzari S, Leonova E, Calabro MG, Amitrano D, Turi S, Prati P, Fresilli S, D'Amico F, D'Andria Ursoleo J, Labanca R, Marmiere M, Pruna A, Scquizzato T, Kirali K, Monti G, Carmona MJC, Tanaka K, Likhvantsev V, Ti LK, Bove T, Paternoster G, Singh K, Gurcu ME, Lomivorotov V, Landoni G, Bellomo R, Zangrillo A; ANH Study Group. A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery. N Engl J Med. 2025 Jul 31;393(5):450-460. doi: 10.1056/NEJMoa2504948. Epub 2025 Jun 12.
PMID: 40503713DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alberto Zangrillo, Prof
Vita-Salute University of Milano
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Associate Professor
Study Record Dates
First Submitted
April 9, 2019
First Posted
April 12, 2019
Study Start
April 15, 2019
Primary Completion
January 19, 2025
Study Completion
December 1, 2025
Last Updated
August 7, 2025
Record last verified: 2025-08